Natera
Trade Natera 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About NTRA
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. It provides Panorama non-invasive prenatal test (NIPT), Vistara, horizon carrier screening (HCS), spectrum pre-implantation genetic screening and spectrum pre-implantation genetic diagnosis, Anora products of conception (POC) and non-invasive paternity testing (PAT).
NTRA Key Statistics
Stock Snapshot
The current Natera(NTRA) stock price is $216.47, with a market capitalization of 31.16B. The stock trades at a price-to-earnings (P/E) ratio of -95.59.
On 2025-11-20, Natera(NTRA) stock traded between a low of $211.98 and a high of $229.95. Shares are currently priced at $216.47, which is +2.1% above the low and -5.9% below the high.
Natera(NTRA) shares are trading with a volume of 3.44M, against a daily average of 1.7M.
During the past year, Natera(NTRA) stock moved between $125.38 at its lowest and $229.95 at its peak.
During the past year, Natera(NTRA) stock moved between $125.38 at its lowest and $229.95 at its peak.
NTRA News
Natera, Inc. reported robust third quarter results, raised its 2025 annual revenue and gross margin forecasts, and announced that Flatiron Health is integrating...
UBS raised the firm’s price target on Natera (NTRA) to $280 from $218 and keeps a Buy rating on the shares. Meet Your ETF AI Analyst Discover how TipRanks' ET...